The fourth publication utilizing SCARD (and part of 3 papers by the same research team) was in May 2022 with the Australasian Journal of Dermatology in a paper called “Characteristics, treatment, and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database.”
The fourth publication utilizing SCARD (and part of 3 papers by the same research team) was in May 2022 with the Australasian Journal of Dermatology in a paper called “Characteristics, treatment, and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database.”
The second publication utilizing SCARD was in the International Journal of Dermatology in a paper called “The impact of subspecialization and dermatoscopy use on accuracy of melanoma diagnosis among primary care doctors in Australia.”
The first publication about SCARD was in the International Journal of Dermatology in a paper called “Measuring Performance in skin cancer practice: the SCARD Initiative.”